In addition, two previously reported bladder cancer risk loci 1p13.3 (glutathiones transferase, GSTM1, deletion) and 8p22 (N-acetyltransferase 2, NAT2, intergenic region) were further validated in the GWAS studies [17, 19, 20]. Here, NAT2 is linked to urinary bladder cancer.